Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Mortality after pancreatic resection has greatly decreased in comparison with historical series, from 33% following Whipple's initial reports to currently less than 2% in most high-volume centers, resulting in the recognition that assessment of surgical quality for these high-acuity patients warrants further refinement. Birkmeyer et al. have demonstrated the impact of hospital volume on actual operative mortality for pancreatic cancer resections, among other high-acuity operations, but these two measures accounted for only half of the hospital-level variation in mortality. Moreover, van der Geest et al. found that the volume-outcome relationship persists in the highest-volume centers (≥40 procedures annually), yet overall morbidity remains high for pancreatic resections, in the range of 35% to 55%. Previously published outcomes after pancreatic resection in a high-volume institution are demonstrated in Table 105.1 ; the three most common complications were delayed gastric emptying (DGE) in 14%, wound infection in 7%, and pancreatic fistula in 5%. This chapter will also discuss postpancreatectomy hemorrhage (PPH).
Overall ( N = 616) | Pancreaticoduodenectomy/Total Pancreatectomy ( n = 564) | Distal Pancreatectomy ( n = 52) | P Value | |
---|---|---|---|---|
Perioperative mortality | 2.3% | 2.3% | 1.9% | NS |
Overall complications | 30% | 31% | 25% | NS |
SPECIFIC COMPLICATIONS | ||||
Reoperation | 3% | 3% | 4% | NS |
Delayed gastric emptying | — | 14% | — | — |
Cholangitis | — | 3% | — | — |
Bile leak | — | 2% | — | — |
Wound infection | 7% | 7% | 5% | NS |
Pancreatic fistula | 5% | 5% | 8% | NS |
Intraabdominal abscess | 3% | 3% | 4% | NS |
Pneumonia | 1% | 1% | 0% | NS |
Pancreatitis | 1% | 1% | 0% | NS |
POSTOPERATIVE LENGTH OF STAY | ||||
Mean ± SE | 13.7 ± 0.4 days | 14.0 ± 0.4 days | 11.5 ± 2.2 days | .08 |
Median | 11 days | 11 days | 7 days | — |
Initial efforts to better understand perioperative mortality after pancreatic resection demonstrated the impact of hospital volume on outcome, with a threefold to fourfold greater operative mortality at low-volume hospitals versus high-volume hospitals. Fong et al. also demonstrate an ongoing survival benefit (6% at 2 years) for patients undergoing pancreatic cancer resection at a high-volume institution. A recent single-institution study reports that higher surgeon volume is associated with shorter operative time, less intraoperative blood loss, and higher lymph node harvest (for cancer cases). However, surgeon experience mitigated these differences, with experienced surgeons (>50 pancreaticoduodenectomies [PDs]) having significantly lower morbidity compared with less experienced surgeons and, in particular, less blood loss, shorter operative time, and a lower postoperative pancreatic fistula (POPF) rate. Twenty PDs were required to equalize the experienced and inexperienced surgeons. However, adequacy of oncologic resection did not differ based on experience.
This chapter will focus on technical and clinical means of preventing and managing pancreatic surgical complications, but the import of surgeon and hospital volume, as well as experience, on complications and overall outcome after pancreatic resection should not be lost on the reader. Schmidt et al. also emphasize the importance of the institution's systems support for the diagnosis and management of postoperative complications (i.e., interventional radiology and gastroenterology, intensive care, and surgical team members).
Hemorrhage associated with pancreatic resection (PPH) occurs in up to 8% of cases but may account for 11% to 38% of mortality. Because of the potential consequences of this problem, a consensus definition was developed by the International Study Group of Pancreatic Surgery (ISGPS) in 2007 and is seen in Table 105.2 . This definition was validated and has been found to correlate well with duration of hospital stay, morbidity, and mortality. It may occur intraoperatively, early in the postoperative period, or late (more than 24 hours postoperatively). Intraoperative hemorrhage may be more likely to occur in the event of aberrant vasculature particularly when not preoperatively identified. Fig. 105.1 demonstrates normal peripancreatic vasculature, as seen on computed tomography (CT) angiography. The common variations include a replaced right hepatic artery (11% to 21%), replaced left hepatic artery (4% to 10%), accessory right or left hepatic artery (<1% to 8%), and celiac artery stenosis (2% to 8%).
Grade | Time of Onset, Location, Severity and Clinical Impact of Bleeding | Clinical Condition | Diagnostic Consequence | Therapeutic Consequence | |
---|---|---|---|---|---|
A | Early, intraluminal or extraluminal, mild | — | Well | Observation, blood count, ultrasonography and, if necessary, computed tomography | No |
B | Early, intraluminal or extraluminal, severe | Late, intraluminal or extraluminal, mild * | Often well/intermediate, very rarely life-threatening | Observation, blood count, ultrasonography, computed tomography, angiography, endoscopy † | Transfusion of fluid/blood, intermediate care unit (or ICU), therapeutic endoscopy, † embolization, relaparotomy for early PPH |
C | Late, intraluminal or extraluminal, severe | Severely impaired, life-threatening | Angiography, computed tomography, endoscopy † | Localization of bleeding, angiography and embolization (endoscopy † ), or relaparotomy, ICU |
* Late, intraluminal or extraluminal, mild bleeding may not be immediately life-threatening to patient but may be a warning sign for later severe hemorrhage (“sentinel bleed”) and is therefore grade B.
† Endoscopy should be performed when signs of intraluminal bleeding are present (melena, hematemesis, or blood loss via nasogastric tube).
Intraoperative vascular complications are known to adversely affect ultimate outcome, including in-hospital mortality and survival rate; thus efforts to delineate vasculature preoperatively by means of a pancreatic protocol CT including arterial, venous, and portal venous phases should allow the surgeon to be better prepared intraoperatively and limit the occurrence of intraoperative hemorrhage related to an unexpected encounter with abnormal vascular anatomy. These efforts should continue intraoperatively by inspection and palpation of the operative field to further define the vascular anatomy. For example, a replaced right hepatic artery may be appreciated by palpation of a pulse posterior and lateral to the bile duct and portal vein. Intraoperative hemorrhage may also occur in the setting of tumor infiltration that involves the relevant vasculature.
To obtain intraoperative control of hemorrhage, direct pressure should be applied initially to allow for mobilization of appropriate anesthetic and surgical resources, such as blood products, vascular sutures, and clamps, and appropriate surgical assistance. Aberrant vasculature, such as a replaced right hepatic artery, may need to be reconstructed or anastomosed to an alternate vessel to preserve hepatic arterial blood flow. Doppler ultrasonography may be useful to determine whether there is already alternate arterial flow. Venous injuries may be able to be addressed with venorrhaphy or with patch venoplasty. In exsanguinating, uncontrolled hemorrhage, portal vein ligation has been described, with a potential for survival, when accompanied by a “second-look” laparotomy in 24 hours to evaluate for signs of ischemia. A more recent paper reports on a small series of patients undergoing damage control laparotomy (DCL) for pancreatic surgery, primarily for portal vein injury, with the goal of allowing intensive care unit (ICU) resuscitation to reverse the accompanying hypothermia, acidosis, and coagulopathy. They describe initial venous compression to allow for identification/visualization of the site of injury, as well as for preparation of the surgical and anesthetic teams. Useful maneuvers for compression included the Kocher maneuver and sponge sticks. The pancreas was then divided and the specimen quickly extirpated when possible. Other techniques used to shorten operating time included external drainage, packing, stapled bowel closure, and rapid abdominal closure. The authors emphasize that there was significant resource use but no mortality. Other risk factors for PPH have been identified including age, pancreatic fistula, pancreatoduodenectomy, and the nutritional risk index (NRI).
Management of early and late PPH is addressed by the ISGPS classification schema. Early PPH is most often a result of technical failure to achieve appropriate hemostasis at the index operation or else secondary to underlying coagulopathy. When significant and thought to be technical failure, prompt relaparotomy is mandated. PPH occurring later than the first postoperative day and up to several weeks postoperatively is often a result of other postoperative complications, such as fistula, anastomotic ulceration, or pseudoaneurysm. PPH may represent bleeding from intraluminal or extraluminal sources: unsecured vessels, vessels with pseudoaneurysm, anastomotic suture lines or ulceration, resection cut surfaces, or hemobilia. Named vascular structures that may be the source of bleeding are the gastroduodenal, hepatic, or splenic artery, branches of the superior mesenteric artery, or the splenic vein stump. The classification system for PPH is described in Table 105.2 .
After PPH becomes apparent, evaluation must occur in a timely fashion and may include a variety of modalities depending on the hemodynamic status of the patient and apparent location of the bleeding (intraluminal or extraluminal): endoscopy, angiography, CT scan, or reoperation. Early extraluminal PPH requires reexploration. Intraluminal bleeding may manifest as extraluminal if there is associated anastomotic breakdown, and this may be amenable to angiographic intervention when involving the pancreaticojejunostomy. Bleeding from the gastrojejunostomy or duodenojejunostomy may first be excluded by endoscopy. Over time, conservative management has become more successful for late PPH but surgical intervention has continued to be the mainstay of treatment. Mortality in patients with late PPH is much higher than for the routine pancreatic resection, with rates of 16% to 27%, but is strongly associated with a bleed in the setting of a septic complication, such as pancreatic fistula. Patients present with septic complications and/or a sentinel bleed. Radiographic embolization has become a more successful modality, with up to 80% success, but is limited by the initially intermittent nature of the bleeding. Furthermore, key factors are the recognition of the sentinel bleed, the presence of pancreatic fistula, and a long gastroduodenal artery stump with radiopaque marker for an effective embolization. Reexploration is indicated when angiographic intervention is not technically feasible or successful or when the site is not visualized on angiography and the patient is hemodynamically unstable.
POPF continues to be the nemesis of pancreatic resection. Occurring in up to 33% of cases, even in the setting of vast improvements in the safety and efficacy of pancreatic surgery overall as mentioned earlier, fistula rates have failed to decrease significantly. One must first recall the definition of fistula as “an abnormal communication from one epithelialized surface to another” compared with that of leakage , referring to “an abnormal escape of fluid through an orifice or opening.”
In addition, POPF occurs with the leakage of amylase-rich fluid from the transection margin of the gland and/or from the pancreatic-enteric anastomosis. Although many literature reports have been devoted to studying the diagnosis, management, and effect of POPF on patient outcome, comparison of these studies has been difficult because there was previously no uniform definition available. To better understand POPF, the ISGPF developed a classification scheme that is presented in Table 105.3 . POPF was defined as inclusive of all peripancreatic fluid collections, abscesses, leaks, or fistulas and diagnosed by virtue of drain amylase, output, imaging, and clinical picture (well versus septic). According to the classification scheme, grade A fistulas are biochemical only and not clinically relevant, whereas grades B and C fistulas are clinically relevant, requiring further evaluation and management, such as antibiotics, nutritional support, octreotide, and percutaneous drainage (grade B) or surgical exploration (grade C) in the setting of sepsis. Subsequent efforts to validate this classification scheme demonstrate that grade A fistulas comprise nearly half of all POPF yet have no apparent significant effect on outcome. However, grade B/C fistulas occur less often (40% and 11%, respectively) but are associated with higher resource use (ICU stay, nursing services post discharge, readmission), longer hospital stay, more complications, and, accordingly, increase in cost, grade for grade.
Criteria | No Fistula | Grade A Fistula | Grade B Fistula | Grade C Fistula |
---|---|---|---|---|
Drain amylase | <3 times normal serum amylase | >3 times normal serum amylase | >3 times normal serum amylase | >3 times normal serum amylase |
Clinical conditions | Well | Well | Often well | Ill appearing/bad |
Specific treatment | No | No | Yes/No | Yes |
Ultrasonography/Computed tomography (if obtained) | Negative | Negative | Negative/positive | Positive |
Persistent drainage (>3 weeks) | No | No | Usually yes | Yes |
Signs of infection | No | No | Yes | Yes |
Readmission | No | No | Yes/No | Yes/No |
Sepsis | No | No | No | Yes |
Reoperation | No | No | No | Yes |
Death related to fistula | No | No | No | Yes |
Prevention of POPF relates to appropriate risk stratification according to endogenous, perioperative, and operative risk factors. A soft gland or diagnoses of ampullary, duodenal, cystic, or islet cell pathologies increases the risk of POPF development by up to 10-fold. Pancreatic duct size is also crucial, with small ducts up to 3 mm in diameter conferring increased risk of POPF, with an odds ratio greater than 3. The Fistula Risk Score has been developed and validated as a predictive tool for surgeons, taking the above factors into account. As for other endogenous risk factors, conflicting information exists in the literature. Some investigators have identified older age, male gender, coronary artery disease, diabetes mellitus, jaundice, and low creatinine clearance as predictors of POPF. However, even though studies have found a correlation between male gender and POPF, these results are weakened by the design of these studies. Moreover, explanations for the impact of gender are still lacking. Interestingly, as a perioperative factor, neoadjuvant therapy appears to reduce the risk of fistula. Operative risk factors for POPF include blood loss higher than 1000 mL, the anastomotic technique, routine drain placement, transanastomotic stents, and longer operative time. Importantly, there appears to be an additive effect of these risk factors, whereby the percentage of patients developing a POPF increases sequentially as the number of risk factors increases, as seen in Table 105.4 , and is associated with increased cost and hospital stay.
Outcomes | No Risk Factors ( n = 63) | 1 Risk Factor ( n = 88) | 2 Risk Factors ( n = 66) | 3 Risk Factors ( n = 13) | 4 Risk Factors ( n = 3) | P value |
---|---|---|---|---|---|---|
Clinically relevant fistulas (%) | 1 (2) | 7 (8) | 16 (24) | 4 (31) | 3 (100) | <.001 |
Nonfistulous complications (%) | 22 (35) | 38 (43) | 38 (58) | 6 (42) | 2 (67) | .113 |
Hospital duration (median, days) | 8 | 8 | 8 | 9 | 19 | .001 |
Total hospital costs (median) | $16,969 | $17,797 | $20,179 | $26,776 | $40,517 | .002 |
Total cost increase (beyond no risk factors) | — | $828 | $3210 | $9807 | $23,548 | — |
Although the incidence of POPF seems to be similar after distal and central pancreatectomy versus proximal pancreatectomy, the clinical course in the setting of a distal resection is milder. However, risk factors particular to distal resections remain poorly understood. Again, a soft gland is predictive of POPF, as well as primary pancreatic pathology and splenic preservation. Division of the pancreas at the body rather than the neck and failure to ligate the main pancreatic duct were also identified as predictors of POPF after distal pancreatectomy. Furthermore, there was no difference in fistula rate for stump closure with suture versus stapler, nor for any demographic measures.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here